OA04.03 A Randomized Phase 3 Study of Camrelizumab Plus Chemotherapy As 1st Line Therapy for Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer C. Zhou , G. Chen , Y. Huang , J. Zhou , L. Lin , J. Feng , Z. Wang , Y. Shu , J. Shi , Y. Hu , Q. Wang , Y. Cheng , J. Chen , X. Lin , Y. Wang , J. Huang , J. Cui , L. Cao , Y. Liu , Y. Zhang , Y. Pan , J. Zhao , L. Wang , J. Chang , Q. Chen , X. Ren , W. Zhang , Y. Fan , Z. He , J. Fang , K. Gu , X. Dong , F. Jin , H. Gao , G. An , C. Ding , X. Jiang , J. Xiong , X. Zhou , S. Hu , P. Lu , A. Liu , S. Guo , C. Zhu , B. Gao , Y. Chen , C. Hu , J. Zhang , H. Zhang , H. Zhao , Y. Zhou , Y. Tai Journal of Thoracic Oncology（2019）
关键词
Non-Squamous Non-Small Cell Lung Cancer, camrelizumab, phase 3
AI 理解论文
溯源树
样例
